COCH
Envoy Medical Inc.
NASDAQ: COCH · HEALTHCARE · MEDICAL DEVICES
$0.68
+0.47% today
Updated 2026-04-30
Market cap
$51.86M
P/E ratio
—
P/S ratio
215.20x
EPS (TTM)
$-1.23
Dividend yield
—
52W range
$0 – $2
Volume
0.3M
Envoy Medical Inc. (COCH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-6.94M | $-8.80M | $-17.09M | $-17.95M | $-18.20M |
| Capital expenditures | $125000.00 | $218000.00 | $153000.00 | $980000.00 | $179000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $1.57M | $562000.00 | $88000.00 |
| Free cash flow | $-7.06M | $-9.02M | $-17.24M | $-18.93M | $-18.38M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $2.45M | $1.82M |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |